Current issue

Issue image

Volume 53, Issue 4, 2025

Online ISSN: 2560-3310

ISSN: 0350-8773

Volume 53 , Issue 4, (2025)

Published: 30.06.2025.

Open Access

All issues

More Filters

Contents

01.01.2011.

Professional paper

DOES DOXORUBICIN CONTAINING CHEMOTHERAPY CHANGE METABOLIC LIVER FUNCTION DURING TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA?

Doxorubicin is antitumor antibiotic extensively metabolized in the liver, and liver antioxidant capacity, including that provided by glutathione production. The aim of this study was to investigate whether doxorubicin containing chemotherapy changes metabolic liver function during treatment of childhood acute lymphoblastic leukaemia. Total protein concentration in serum, concentration of total, conjugated and non conjugated bilirubin, activity of aspartat aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl transferase (ãGT), lactate dehydrogenase and creatin kinase activity were measured before and after treatment with doxorubicin containing chemotherapy and in the control group. Caffeine was applied as metabolic marker via controlled consummation of Coca-Cola and 8-hour urine was collected immediately afterwards. In the collected samples, urinary thioethers and caffeine metabolites concentrations were measured. Chemotherapeutic regiment established for initial treatment of childhood ALL containing prednisone, vincristine, doxorubicin and L-asparaginase did not alter metabolic liver function. This regiment did not change liver enzyme activity. Applied chemotherapy also did not alter caffeine biotransformation, but it did increase urinary thioethers excretion. 

J. Kolarović, N. Konstantinidis, N. Kaćanski, J. Katanić

01.12.2009.

Original scientific paper

INFLUENCE OF DOXORUBICIN ON ELECTRICAL ACTIVITY OF THE MYOCARDIUM AND LEFT VENTRICULAR FUNCTION DURING TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

Doxorubicin is the most frequently used anthracycline antibiotic that expresses significant toxicity. Among all side  effects, hematological are the most common, while cardiac side effects are the most serious and the most important. The aim of this study was to investigate whether doxorubicin containing combined chemotherapy used in treatment of childhood acute lymphoblastic leukemia (ALL), influences electrical activity of the myocardium and left ventricular function in affected children. Experimental group consisted of 20 children with newly diagnosed ALL treated according to protocol YU ALL 95, while the control group consisted of 20 healthy children. Electrocardiograms (ECG) at rest were taken and analyzed, and corrected QT intervals (QTc) calculated. All children had echocardiograms (ECHO) including fractional shortening (FS) and ejection fraction (EF). Electrocardiograms, FS and EF were normal in all subjects, and were similar in both groups.

J. kolarović, N. Konstantinidis, Lj. Milić-Georgijević, N. Kaćanski, G. Novović

Indexed by